The Effect of Nano-Epigallocatechin-Gallate on Oxidative Stress and Matrix Metalloproteinases in Experimental Diabetes Mellitus

Abstract

Background: The antioxidant properties of epigallocatechin-gallate (EGCG), a green tea compound, have been already studied in various diseases. Improving the bioavailability of EGCG by nanoformulation may contribute to a more effective treatment of diabetes mellitus (DM) metabolic consequences and vascular complications. The aim of this study was to test the comparative effect of liposomal EGCG with EGCG solution in experimental DM induced by streptozotocin (STZ) in rats. Method: 28 Wistar-Bratislava rats were randomly divided into four groups (7 animals/group): group 1—control group, with intraperitoneal (i.p.) administration of 1 mL saline solution (C); group 2—STZ administration by i.p. route (60 mg/100 g body weight, bw) (STZ); group 3—STZ administration as before + i.p. administration of EGCG solution (EGCG), 2.5 mg/100 g b.w. as pretreatment; group 4—STZ administration as before + i.p. administration of liposomal EGCG, 2.5 mg/100 g b.w. (L-EGCG). The comparative effects of EGCG and L-EGCG were studied on: (i) oxidative stress parameters such as malondialdehyde (MDA), indirect nitric oxide (NOx) synthesis, and total oxidative status (TOS); (ii) antioxidant status assessed by total antioxidant capacity of plasma (TAC), thiols, and catalase; (iii) matrix-metalloproteinase-2 (MMP-2) and -9 (MMP-9). Results: L-EGCG has a better efficiency regarding the improvement of oxidative stress parameters (highly statistically significant with p-values < 0.001 for MDA, NOx, and TOS) and for antioxidant capacity of plasma (highly significant p < 0.001 for thiols and significant for catalase and TAC with p < 0.05). MMP-2 and -9 were also significantly reduced in the L-EGCG-treated group compared with the EGCG group (p < 0.001). Conclusions: the liposomal nanoformulation of EGCG may serve as an adjuvant therapy in DM due to its unique modulatory effect on oxidative stress/antioxidant biomarkers and MMP-2 and -9.

Yuzu and Hesperidin Ameliorate Blood-Brain Barrier Disruption during Hypoxia via Antioxidant Activity

“…Indeed, many reports suggest that ROS are key mediators of BBB breakdown, implicating antioxidants as potential neuroprotectants against BBB-associated brain damage. ROS have also been suggested to provide a common trigger for many downstream pathways that directly mediate BBB dysfunction, such as TJ modification, and MMP activation [ 41 , 42 ]. In BBB endothelial cells, it has been shown that ROS causes DNA damage by induction of cell death, membrane lipid peroxidation, and increased permeability [ 43 , 44 ].…”

Tuftsin-Bearing Liposomes Co-Encapsulated with Doxorubicin and Curcumin Efficiently Inhibit EAC Tumor Growth in Mice

“…Furthermore, in this study liposomes were used as nanocarriers, owing to its enhanced stability, bioavailability, and shelf life for sensitive ingredients as they are assembled from phospholipid bilayers similar to cell membranes and their biphasic character making them suitable for being carriers for both hydrophilic (in the central aqueous compartment) and hydrophobic (in lipid bilayers) compound. 26,27 Tuftsin a tetrapeptide (Thr-Lys-Pro-Arg) stimulates immunomodulatory effects by binding specifically to macrophages, monocytes, and polymorphonuclear leukocytes (PMN). 28 Many studies have reported the anti-tumor efficacy of tuftsin in animal models.…”

Anti-Cancer Effects of Green Tea Epigallocatchin-3-Gallate and Coffee Chlorogenic Acid

“…Actually, Bulboaca, et al showed that i.p. administration of EGCG or liposomal EGCG improved the oxidative stress parameters such as malondialdehyde levels and nitric oxide (NO) synthesis as well as those of anti-oxidant status as evaluated by total anti-oxidant capacity and levels of thiols and catalase in plasma of rats treated with streptozotocin [ 46 ].…”